ES2768198T3 - Calibración para ensayos de múltiples componentes - Google Patents
Calibración para ensayos de múltiples componentes Download PDFInfo
- Publication number
- ES2768198T3 ES2768198T3 ES14728186T ES14728186T ES2768198T3 ES 2768198 T3 ES2768198 T3 ES 2768198T3 ES 14728186 T ES14728186 T ES 14728186T ES 14728186 T ES14728186 T ES 14728186T ES 2768198 T3 ES2768198 T3 ES 2768198T3
- Authority
- ES
- Spain
- Prior art keywords
- calibration
- signal
- analyzer
- components
- predetermined number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 30
- 238000003556 assay Methods 0.000 claims abstract description 61
- 238000000034 method Methods 0.000 claims abstract description 53
- 239000012472 biological sample Substances 0.000 claims abstract description 42
- 239000012491 analyte Substances 0.000 claims abstract description 18
- 238000005375 photometry Methods 0.000 claims abstract description 5
- 238000000411 transmission spectrum Methods 0.000 claims abstract description 4
- 230000006870 function Effects 0.000 claims description 61
- 238000005259 measurement Methods 0.000 claims description 58
- 239000002245 particle Substances 0.000 claims description 50
- 108010074051 C-Reactive Protein Proteins 0.000 claims description 28
- 102100032752 C-reactive protein Human genes 0.000 claims description 28
- 238000003860 storage Methods 0.000 claims description 25
- 241001529936 Murinae Species 0.000 claims description 10
- 230000005540 biological transmission Effects 0.000 claims description 8
- 230000000704 physical effect Effects 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 4
- 238000002848 electrochemical method Methods 0.000 claims description 4
- 230000005258 radioactive decay Effects 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims 1
- 239000004816 latex Substances 0.000 description 19
- 229920000126 latex Polymers 0.000 description 19
- 238000011088 calibration curve Methods 0.000 description 18
- 239000000523 sample Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000004422 calculation algorithm Methods 0.000 description 8
- 238000004590 computer program Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000003851 biochemical process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000007620 mathematical function Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
- 102000015833 Cystatin Human genes 0.000 description 1
- 102000012192 Cystatin C Human genes 0.000 description 1
- 108010061642 Cystatin C Proteins 0.000 description 1
- 101000912205 Homo sapiens Cystatin-C Proteins 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 230000009831 antigen interaction Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006854 communication Effects 0.000 description 1
- 108050004038 cystatin Proteins 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 102000049632 human CST3 Human genes 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000002922 simulated annealing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000007817 turbidimetric assay Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00693—Calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00693—Calibration
- G01N2035/00702—Curve-fitting; Parameter matching; Calibration constants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/59—Transmissivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/127—Calibration; base line adjustment; drift compensation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4737—C-reactive protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Quality & Reliability (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Electrochemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13171044.4A EP2811300A1 (en) | 2013-06-07 | 2013-06-07 | Calibration for multi-component assays |
| PCT/EP2014/061571 WO2014195355A1 (en) | 2013-06-07 | 2014-06-04 | Calibration for multi-component assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2768198T3 true ES2768198T3 (es) | 2020-06-22 |
Family
ID=48578854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14728186T Active ES2768198T3 (es) | 2013-06-07 | 2014-06-04 | Calibración para ensayos de múltiples componentes |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11378573B2 (enExample) |
| EP (2) | EP2811300A1 (enExample) |
| JP (1) | JP6419791B2 (enExample) |
| CN (1) | CN105637365B (enExample) |
| CA (1) | CA2904256C (enExample) |
| ES (1) | ES2768198T3 (enExample) |
| WO (1) | WO2014195355A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2900201C (en) * | 2014-08-25 | 2025-01-07 | Bio Rad Laboratories Inc | VALUE ASSIGNMENT TO CUSTOMIZABLE QUALITY CONTROLS |
| CN108369387B (zh) | 2015-12-17 | 2020-11-03 | Asml荷兰有限公司 | 使用非对称亚分辨率特征改善测量的光刻过程的光学量测术 |
| WO2017216208A1 (en) * | 2016-06-15 | 2017-12-21 | Roche Diagnostics Gmbh | Improved d-dimer assay calibration |
| WO2018099859A1 (en) * | 2016-12-02 | 2018-06-07 | Roche Diagnostics Gmbh | Failure state prediction for automated analyzers for analyzing a biological sample |
| US11209417B2 (en) * | 2017-10-12 | 2021-12-28 | Carrot, Inc. | Breath sensor apparatus and methods of use |
| CN111239426B (zh) * | 2018-11-29 | 2023-12-01 | 深圳市帝迈生物技术有限公司 | 样本分析仪及其自动校准的方法 |
| GB2579810B (en) * | 2018-12-14 | 2023-04-26 | Aeirtec Ltd | Assay Analysis |
| CN113474662A (zh) | 2018-12-28 | 2021-10-01 | 贝克曼库尔特有限公司 | 临床分析仪自动化系统诊断 |
| JP2020201174A (ja) * | 2019-06-12 | 2020-12-17 | 国立研究開発法人物質・材料研究機構 | スペクトル解析装置用の成分同定装置及びその方法、コンピュータプログラム |
| EP3757547B1 (en) * | 2019-06-28 | 2022-11-23 | ABB Schweiz AG | Turbidity calibration-correction apparatus and method for an automated calibration correction |
| EP4078652A1 (en) * | 2019-12-17 | 2022-10-26 | F. Hoffmann-La Roche AG | Method for calibrating at least one mass spectrometry device |
| JP7583812B2 (ja) * | 2019-12-17 | 2024-11-14 | エフ． ホフマン－ラ ロシュ アーゲー | 複数の反復ハードウェア構成要素を有する少なくとも１つの分析装置を較正するための方法 |
| EP4084684A4 (en) | 2019-12-31 | 2024-03-27 | McNeil AB | METHOD AND DEVICE FOR CALIBRATION OF BREATH SENSORS |
| CN112462078A (zh) * | 2020-11-16 | 2021-03-09 | 三诺生物传感股份有限公司 | 一种用于荧光免疫分析仪台间差校准的方法 |
| CN112730203B (zh) * | 2020-12-29 | 2023-06-16 | 深圳市科曼医疗设备有限公司 | 血球分析仪的光学系统、光学增益校准方法和存储介质 |
| AU2022206320A1 (en) * | 2021-01-11 | 2023-07-27 | Meso Scale Technologies, Llc. | Assay system calibration systems and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3645023B2 (ja) * | 1996-01-09 | 2005-05-11 | 富士写真フイルム株式会社 | 試料分析方法、検量線の作成方法及びそれを用いる分析装置 |
| EP0898169B1 (en) * | 1997-08-11 | 2002-02-06 | F. Hoffmann-La Roche Ag | Microparticle enhanced light scattering assay and microparticle reagents therefor |
| CA2244326C (en) * | 1997-08-11 | 2006-03-28 | Shinichi Eda | Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor |
| US6277584B1 (en) * | 1998-12-16 | 2001-08-21 | Dade Behring Inc. | Method for calibrating a chemical analyzer with improved accuracy at low signal levels |
| DE60334365D1 (de) * | 2002-03-22 | 2010-11-11 | Animas Technologies Llc | Leistungsverbesserung einer analytenüberwachungsvorrichtung |
| JP4331073B2 (ja) * | 2004-08-31 | 2009-09-16 | デンカ生研株式会社 | 抗原の測定方法及びそのための試薬 |
| JP2009063335A (ja) * | 2007-09-05 | 2009-03-26 | Fujifilm Corp | 生理活性物質と被験物質との相互作用の測定方法 |
| CN102216784B (zh) * | 2008-11-17 | 2014-07-09 | 株式会社日立高新技术 | 自动分析装置 |
| JP5554247B2 (ja) * | 2008-12-04 | 2014-07-23 | 積水メディカル株式会社 | ヒト体液中のシスタチンｃ測定方法 |
-
2013
- 2013-06-07 EP EP13171044.4A patent/EP2811300A1/en not_active Withdrawn
-
2014
- 2014-06-04 CA CA2904256A patent/CA2904256C/en active Active
- 2014-06-04 JP JP2016517286A patent/JP6419791B2/ja active Active
- 2014-06-04 CN CN201480027599.6A patent/CN105637365B/zh active Active
- 2014-06-04 WO PCT/EP2014/061571 patent/WO2014195355A1/en not_active Ceased
- 2014-06-04 ES ES14728186T patent/ES2768198T3/es active Active
- 2014-06-04 EP EP14728186.9A patent/EP3004880B1/en active Active
-
2015
- 2015-12-02 US US14/956,733 patent/US11378573B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014195355A1 (en) | 2014-12-11 |
| HK1220758A1 (zh) | 2017-05-12 |
| CN105637365A (zh) | 2016-06-01 |
| CA2904256A1 (en) | 2014-12-11 |
| US20160084861A1 (en) | 2016-03-24 |
| EP3004880B1 (en) | 2019-11-20 |
| US11378573B2 (en) | 2022-07-05 |
| CA2904256C (en) | 2019-09-10 |
| EP3004880A1 (en) | 2016-04-13 |
| JP2016523359A (ja) | 2016-08-08 |
| JP6419791B2 (ja) | 2018-11-07 |
| CN105637365B (zh) | 2018-04-24 |
| EP2811300A1 (en) | 2014-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2768198T3 (es) | Calibración para ensayos de múltiples componentes | |
| ES2768201T3 (es) | Procedimiento de calibración para fotometría y sistema de análisis asociado | |
| ES2636925T3 (es) | Procedimiento para la detección del efecto prozona de ensayos fotométricos | |
| Thachil et al. | D-dimer testing: laboratory aspects and current issues | |
| Dimeski | Interference testing | |
| Hillström et al. | Validation of a commercially available automated canine‐specific immunoturbidimetric method for measuring canine C‐reactive protein | |
| Leligdowicz et al. | Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection | |
| Krzeminska et al. | Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA | |
| JP2016523359A5 (enExample) | ||
| Hindenberg et al. | Evaluation of a novel quantitative canine species-specific point-of-care assay for C-reactive protein | |
| Jasensky et al. | Evaluation of three different point‐of‐care tests for quantitative measurement of canine C‐reactive protein | |
| Zhang et al. | Commutability of possible external quality assessment materials for cardiac troponin measurement | |
| Mondésert et al. | A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings | |
| CN111323393A (zh) | 一种联合散射比浊法和透射比浊法的测量方法 | |
| ES2773775T3 (es) | Ventanas de tiempo múltiples para extender el rango de un ensayo | |
| Geertjens et al. | Straightforward model construction and analysis of multicomponent biomolecular systems in equilibrium | |
| CN112485439A (zh) | 特定蛋白质反应检测方法、蛋白质检测装置和定标方法 | |
| JP2006250787A (ja) | クロマトグラフィー測定装置 | |
| Liu et al. | Development of a fully automated latex-enhanced immunoturbidimetric method for quantitative serum Lp (a) measurement | |
| JP3332167B2 (ja) | マイクロプレートリーダー | |
| Yong et al. | Expedient measurement of total protein in human serum and plasma via the biuret method using fiber optic probe for patient samples and certified reference materials | |
| Connolly et al. | Evaluation of a point‐of‐care benchtop analyzer for quantitative measurement of C‐reactive protein in canine serum and plasma | |
| Geertjens et al. | A general framework for straightforward model construction of multi-component thermodynamic equilibrium systems | |
| HK1220758B (en) | Calibration for multi-component assays | |
| Allison et al. | B-083 Validation of Alzheimer’s Disease Markers in CSF |